Ebola Bundibugyo Outbreak in DRC and Uganda Declared Global Emergency

The Democratic Republic of Congo (DRC) and neighboring Uganda are currently grappling with a severe outbreak of Ebola disease, specifically caused by the Bundibugyo virus, as confirmed by the World Health Organization (WHO) and other international health bodies. This constitutes the DRC's 17th Ebola outbreak since the virus was first identified in 1976. The outbreak was officially declared by the Ministry of Health of the Democratic Republic of Congo on May 15, 2026, originating in the Ituri Province in the northeastern part of the country. Just two days later, on May 17, 2026, the WHO Director-General declared the situation a Public Health Emergency of International Concern (PHEIC), signifying its serious nature and potential for global spread, requiring coordinated international response. This declaration followed the identification of confirmed cases in Uganda, epidemiologically linked to the transmission in the DRC. As of June 17, 2026, the Democratic Republic of Congo had reported a cumulative total of 896 confirmed cases, including 232 deaths. Uganda, as of June 18, 2026, had recorded 19 confirmed cases, including two deaths, along with one probable case that resulted in death. The cases in Uganda include both imported infections from the DRC and instances of secondary transmission among contacts and healthcare workers, primarily in the Kampala Metropolitan Area. However, Uganda has not reported new cases since June 5, 2026, suggesting a more stable situation there, though vigilance remains high. A critical aspect of this outbreak is that it is caused by the Bundibugyo ebolavirus, a strain for which there is currently no licensed vaccine or specific antiviral treatment. This contrasts with the more widely known Zaire ebolavirus, which caused the major 2014-2016 West Africa outbreak and the 2018-2020 outbreak in North Kivu, for which vaccines exist. The lack of specific countermeasures for Bundibugyo virus disease (BVD) means that response strategies rely heavily on traditional public health measures. These include rapid case identification, patient isolation and supportive care, rigorous contact tracing, strict infection prevention and control protocols, safe burial practices, and extensive community engagement. The response efforts are further complicated by the volatile and complex humanitarian, security, and epidemiological landscape in eastern DRC. The region is characterized by ongoing armed conflict, insecurity, highly mobile populations (including cross-border movements and trade flows often linked to mining), and the presence of large displaced and refugee communities. These factors significantly hinder effective surveillance, contact tracing, and the safe delivery of humanitarian aid. For instance, contact tracing efforts are currently below the WHO's target benchmarks for effective containment, with only 56% of identified contacts being reached as of mid-June 2026. Mistrust in communities, stemming from decades of conflict and unfulfilled promises, also poses a significant challenge to public health interventions. International organizations, including WHO, CDC, and various UN agencies like IOM and UNHCR, are actively supporting the governments of the DRC and Uganda. Support includes deploying technical experts, providing medical supplies, enhancing laboratory testing capacities, strengthening infection prevention and control, and reinforcing emergency coordination systems. Cross-border coordination is a major focus, with screenings implemented at points of entry and along key travel corridors to prevent further spread. Research and development initiatives are also being mobilized to identify and advance potential medical countermeasures for BVD. Given the ongoing challenges, including the rapid increase in cases in DRC and the lack of a specific vaccine, the international community emphasizes the critical importance of community engagement to ensure acceptance and adherence to public health measures. The outbreak underscores the fragility of health systems in conflict-affected areas and the need for sustained international cooperation to prevent the widespread impact of such deadly diseases.

Frequently Asked Questions

Read Full Story on Quick Digest